198 related articles for article (PubMed ID: 19772)
41. Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule.
Chiang FK; Cheng RK; Liao RM
Pharmacol Biochem Behav; 2015 Mar; 130():67-76. PubMed ID: 25584855
[TBL] [Abstract][Full Text] [Related]
42. Preselection of animals in studies of anti-anxiety drugs.
Soubrie P; Wlodaver C; Schoonhoed L; Simon P; Boissier JR
Neuropharmacology; 1974 Aug; 13(8):719-28. PubMed ID: 4444758
[No Abstract] [Full Text] [Related]
43. Prior and ongoing experience as determinants of the effects of d-amphetamine and chlorpromazine on punished behavior.
Bacotti AV; McKearney JW
J Pharmacol Exp Ther; 1979 Oct; 211(1):80-5. PubMed ID: 114623
[No Abstract] [Full Text] [Related]
44. Drug effects on multiple and alternating mixed-schedule performance.
Leander JD
J Pharmacol Exp Ther; 1981 Sep; 218(3):728-33. PubMed ID: 7264956
[TBL] [Abstract][Full Text] [Related]
45. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
Commissaris RL; Semeyn DR; Moore KE; Rech RH
Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
[No Abstract] [Full Text] [Related]
46. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
Louis C; Cohen C; Depoortère R; Griebel G
Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
[TBL] [Abstract][Full Text] [Related]
47. Adaptive changes in behavior after repeated administration of various psychoactive drugs.
Rech RH; Tilson HA; Marquis WJ
Adv Biochem Psychopharmacol; 1975; 13():263-86. PubMed ID: 1163377
[TBL] [Abstract][Full Text] [Related]
48. The effects of d-amphetamine and diazepam on schedule-induced defecation in rats.
LeSage M; Makhay M; DeLeon I; Poling A
Pharmacol Biochem Behav; 1994 Jul; 48(3):787-90. PubMed ID: 7938136
[TBL] [Abstract][Full Text] [Related]
49. Effects of d-amphetamine, morphine and chlorpromazine on responding under fixed-interval schedules of food presentation or electric shock presentation.
McKearney JW
J Pharmacol Exp Ther; 1974 Jul; 190(1):141-53. PubMed ID: 4211164
[No Abstract] [Full Text] [Related]
50. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. I. Antipsychotic and anxiolytic activity in comparison with chlorpromazine, clozapine, diazepam and buspirone.
Ruhland M; Krähling H; Fuchs A; Schön U
Pharmacopsychiatry; 1988 Nov; 21(6):396-8. PubMed ID: 2907649
[No Abstract] [Full Text] [Related]
51. Spontaneous activity as a contingency-controlled behavior within an operant context: alprazolam concentration-effect relations after subcutaneous administration in rats.
Simpao A; Sun L; Falk JL; Lau CE
Psychopharmacology (Berl); 2001 May; 155(3):269-77. PubMed ID: 11432689
[TBL] [Abstract][Full Text] [Related]
52. Effects of cinanserin and p-chlorophenylalanine and their interaction with d-amphetamine on DRL performance in rats.
Mele PC; Caplan MA
Pharmacol Biochem Behav; 1980 Jun; 12(6):883-91. PubMed ID: 6447298
[No Abstract] [Full Text] [Related]
53. Effects of clozapine on fixed-consecutive-number responding in rats: a comparison to other neuroleptic drugs.
Picker M
Pharmacol Biochem Behav; 1988 Jul; 30(3):603-12. PubMed ID: 2905469
[TBL] [Abstract][Full Text] [Related]
54. Effects of psychoactive drugs on operant responding and non-operant activity of rats with hippocampal system damage.
Shull RN; Holloway FA
Brain Res Bull; 1986 Apr; 16(4):483-90. PubMed ID: 3719379
[TBL] [Abstract][Full Text] [Related]
55. Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
Bespalov AY; van Gaalen MM; Sukhotina IA; Wicke K; Mezler M; Schoemaker H; Gross G
Eur J Pharmacol; 2008 Sep; 592(1-3):96-102. PubMed ID: 18634781
[TBL] [Abstract][Full Text] [Related]
56. DRL performance in 6-hydroxydopamine-treated rats.
Levine TE; McGuire PS; Heffner TG; Seiden LS
Pharmacol Biochem Behav; 1980 Feb; 12(2):287-91. PubMed ID: 7375491
[TBL] [Abstract][Full Text] [Related]
57. Thigmotaxis as a test for anxiolytic activity in rats.
Treit D; Fundytus M
Pharmacol Biochem Behav; 1988 Dec; 31(4):959-62. PubMed ID: 3252289
[TBL] [Abstract][Full Text] [Related]
58. [Use of pharmacologic substances and instrumental reflex methods to analyze the nature of the self stimulation reaction].
Kirillova OI
Nauchnye Doki Vyss Shkoly Biol Nauki; 1978; (8):66-73. PubMed ID: 708809
[No Abstract] [Full Text] [Related]
59. Spatial and paw preferences in rats: their relationship to rate-dependent effects of d-amphetamine.
Glick SD; Jerussi TP
J Pharmacol Exp Ther; 1974 Mar; 188(3):714-25. PubMed ID: 4816334
[No Abstract] [Full Text] [Related]
60. Effects of promazine, chlorpromazine, d-amphetamine, and pentobarbital on treadle pressing by pigeons under a signalled shock-postponement schedule.
Leander JD
J Exp Anal Behav; 1976 Nov; 26(3):361-8. PubMed ID: 1003071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
